These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2633614)
1. The basis for intrinsic drug resistance or sensitivity to methotrexate. Bertino JR; Lin J; Pizzorno G; Li WW; Chang YM Adv Enzyme Regul; 1989; 29():277-85. PubMed ID: 2633614 [TBL] [Abstract][Full Text] [Related]
2. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance. Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240 [TBL] [Abstract][Full Text] [Related]
3. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug. Pizzorno G; Chang YM; McGuire JJ; Bertino JR Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246 [TBL] [Abstract][Full Text] [Related]
4. Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection. Lacerda JF; Göker E; Kheradpour A; Dennig D; Elisseyeff Y; Jagiello C; O'Reilly RJ; Bertino JR Blood; 1995 May; 85(10):2675-9. PubMed ID: 7742525 [TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines. McGuire JJ; Magee KJ; Russell CA; Canestrari JM Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation. Gorlick R; Cole P; Banerjee D; Longo G; Li WW; Hochhauser D; Bertino JR Adv Exp Med Biol; 1999; 457():543-50. PubMed ID: 10500832 [TBL] [Abstract][Full Text] [Related]
7. Congruence of SQM1 protein expression with methotrexate sensitivity and transport. Bernal SD; de Villa RS; Wong YC Cancer Invest; 1995; 13(1):23-30. PubMed ID: 7834471 [TBL] [Abstract][Full Text] [Related]
8. Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. Trippett T; Schlemmer S; Elisseyeff Y; Goker E; Wachter M; Steinherz P; Tan C; Berman E; Wright JE; Rosowsky A Blood; 1992 Sep; 80(5):1158-62. PubMed ID: 1381235 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules. van der Laan BF; Jansen G; Kathmann I; Schornagel JH; Hordijk GJ Eur J Cancer; 1991; 27(10):1274-8. PubMed ID: 1835598 [TBL] [Abstract][Full Text] [Related]
11. Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines. Li WW; Lin JT; Schweitzer BI; Tong WP; Niedzwiecki D; Bertino JR Cancer Res; 1992 Jul; 52(14):3908-13. PubMed ID: 1377601 [TBL] [Abstract][Full Text] [Related]
12. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells. Chen G; Wright JE; Rosowsky A Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the effect of AG337, a novel lipophilic thymidylate synthase inhibitor, on human head and neck and human leukemia cell lines. McGuire JJ; Canestrari JG; Nagel GS Int J Oncol; 1999 Dec; 15(6):1245-50. PubMed ID: 10568835 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
16. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II). Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492 [TBL] [Abstract][Full Text] [Related]
17. Carboxypeptidase G2 enhances trimetrexate cytotoxicity in CCRF-CEM cell lines sensitive and resistant to methotrexate. Romanini A; Chou TC; Bertino JR Adv Enzyme Regul; 1989; 28():323-33. PubMed ID: 2533849 [TBL] [Abstract][Full Text] [Related]
18. Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia. Lin JT; Tong WP; Trippett TM; Niedzwiecki D; Tao Y; Tan C; Steinherz P; Schweitzer BI; Bertino JR Leuk Res; 1991; 15(12):1191-6. PubMed ID: 1722550 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate. van der Laan BF; Jansen G; Kathmann GA; Westerhof GR; Schornagel JH; Hordijk GJ Int J Cancer; 1992 Jul; 51(6):909-14. PubMed ID: 1639538 [TBL] [Abstract][Full Text] [Related]
20. Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture. Frei E; Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Ervin TJ; Jolivet J; Haseltine WA Proc Natl Acad Sci U S A; 1984 May; 81(9):2873-7. PubMed ID: 6201865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]